FLDDW
Fold Holdings, Inc. WarrantKey Statistics
About Fold Holdings, Inc. Warrant
Fold Holdings, Inc. Warrant is a biotechnology firm committed to developing innovative therapeutic solutions for rare genetic disorders. The company boasts a robust pipeline of proprietary drug candidates that are currently progressing through clinical development, underscoring its dedication to addressing significant unmet medical needs. With a clear focus on innovation and transformative treatment approaches, Fold Holdings presents an attractive opportunity for institutional investors looking to diversify their portfolios within the biopharmaceutical sector, especially as it targets underserved patient populations.
Fundamentals
| Revenue (TTM) | $28.21M |
| Gross Profit (TTM) | $-13.48M |
| EBITDA | $-31.10M |
| Operating Margin | -139.80% |
| Return on Equity | -121.80% |
| Return on Assets | -16.80% |
| Revenue/Share (TTM) | $0.57 |
| Book Value | $0.72 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 1622.00% |
| Quarterly Revenue Growth (YoY) | -25.50% |
| Shares Outstanding | 0 |
| Float | $6.74M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on FLDDW and any ticker you trade — then tracks every position and per-strategy win rate.